Joohee Sul

Company: Sul Clinical

Job title: Consultant

Seminars:

Panel Discussion: Is Prioritizing Combination Therapy Over Monotherapy the Most Promising Avenue for Overcoming Heterogeneity? 4:30 pm

Understand the shortfalls of key therapy types with regard to targeting tumor heterogeneity and how combination therapies can be used to strategically overcome these Combine drug treatments with radiotherapy or tumor treating fields Are combination therapies considered ‘too risky’ from a regulatory standpoint? Understand how the regulatory framework can best support the approval of combination…Read more

day: Conference Day 1